Limited Competition for the Continuation of the Adult Acute Liver Failure Study Group (U01)

The summary for the Limited Competition for the Continuation of the Adult Acute Liver Failure Study Group (U01) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Limited Competition for the Continuation of the Adult Acute Liver Failure Study Group (U01): Purpose. This Funding Opportunity Announcement (FOA) issued by the NIDDK, National Institutes of Health is to invite a cooperative agreement (U01) application for the competing continuation of the Adult Acute Liver Failure Study Group. Mechanism of Support. This FOA will utilize the NIH Cooperative Agreement (U01) grant mechanism. Funds Available and Anticipated Number of Awards. The total amount of funding that the NIDDK expects to award through this announcement is $10 million for one award.

Federal Grant Title:	Limited Competition for the Continuation of the Adult Acute Liver Failure Study Group (U01)
Federal Agency Name:	National Institutes of Health
Grant Categories:	Food and Nutrition Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	RFA-DK-09-506
Type of Funding:	Cooperative Agreement
CFDA Numbers:	93.847
CFDA Descriptions:	Diabetes, Endocrinology and Metabolism Research
Current Application Deadline:	Mar 15, 2010
Original Application Deadline:	Mar 15, 2010
Posted Date:	Jan 07, 2010
Creation Date:	Jan 07, 2010
Archive Date:	Apr 15, 2010
Total Program Funding:	$10,000,000
Maximum Federal Grant Award:	$600,000
Minimum Federal Grant Award:
Expected Number of Awards:	1
Cost Sharing or Matching:	No

Applicants Eligible for this Grant: Public and State controlled institutions of higher education - Private institutions of higher education
Link to Full Grant Announcement: Information not provided
Grant Announcement Contact: NIH OER [email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [[email protected]]
Similar Government Grants: • Cystic Fibrosis Research and Translation Centers (P30 Clinical Trial Optional); • Kidney Technology Development Research Education Program (R25 - Independent Clinical Trial...; • Adaptation of Diabetes Control Technologies for Older Adults with T1D (R01 Clinical Trial...; • Discovery of Early Type 1 Diabetes Disease Processes in the Human Pancreas [HIRN Consortiu...; • Diabetes Research Centers (P30 Clinical Trial Optional); • Proteomic and Metabolomic Approaches to Diagnose Diabetes and Pre-Diabetes; • Molecular Therapy Core Centers; • Pilot and Feasibility Program in Human Islet Biology
More Grants from the National Institutes of Health: • NIH Pathway to Independence Award (Parent K99/R00 Independent Clinical Trial Not Allowed); • NIH Pathway to Independence Award (Parent K99/R00 Independent Clinical Trial Required); • Safety and Early Efficacy Studies of Psychedelic-Assisted Therapy for Chronic Pain in Olde...; • NIH Pathway to Independence Award (Parent K99/R00 Independent Basic Experimental Studies w...; • Mentored Research Scientist Development Award (Parent K01 Independent Basic Experimental S...